GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ACADIA Pharmaceuticals Inc (FRA:DR6) » Definitions » Inventories, Other

ACADIA Pharmaceuticals (FRA:DR6) Inventories, Other : €21.0 Mil (As of Dec. 2024)


View and export this data going back to 2004. Start your Free Trial

What is ACADIA Pharmaceuticals Inventories, Other?

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. ACADIA Pharmaceuticals's other inventories for the quarter that ended in Dec. 2024 was €21.0 Mil.

ACADIA Pharmaceuticals's quarterly other inventories declined from Jun. 2024 (€0.0 Mil) to Sep. 2024 (€0.0 Mil) but then increased from Sep. 2024 (€0.0 Mil) to Dec. 2024 (€21.0 Mil).

ACADIA Pharmaceuticals's annual other inventories increased from Dec. 2022 (€6.3 Mil) to Dec. 2023 (€32.8 Mil) but then declined from Dec. 2023 (€32.8 Mil) to Dec. 2024 (€21.0 Mil).

ACADIA Pharmaceuticals Inventories, Other Historical Data

The historical data trend for ACADIA Pharmaceuticals's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ACADIA Pharmaceuticals Inventories, Other Chart

ACADIA Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Other
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 6.26 32.85 20.96

ACADIA Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventories, Other Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.85 - - - 20.96

ACADIA Pharmaceuticals Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.

ACADIA Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ACADIA Pharmaceuticals Inc (FRA:DR6) » Definitions » Inventories, Other
Comparable Companies
BHVN VKTX MTSR CPRX PTGX IBRX APLS XENE MRUS FOLD VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
ACAD:USA DR6:Germany
Address
12830 El Camino Real, Suite 400, San Diego, CA, USA, 92130
Website
https://www.acadia.com
Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuroscience and neuro-rare diseases. The neuroscience franchise is anchored by its commercial product NUPLAZID (pimavanserin), which is used for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis (PDP). The neuro-rare disease franchise is anchored by the commercial product DAYBUE, which is used for the treatment of Rett syndrome. In addition, the company has various product candidates under development in different stages, including ACP-204, ACP-101, ACP-211, ACP-711, ACP-2591, etc.

ACADIA Pharmaceuticals Headlines

No Headlines